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Summary of human Vibrio isolates reported to CDC, 2005 
Infection with toxigenic Vibrio cholerae serogroups O1 and O139, the causative agents of 
cholera, has been a reportable disease in the United States for many years.  In addition, since 
1988, CDC has maintained a database of reported infection with any species of Vibrio from 
humans in order to obtain reliable information on illnesses associated with the range of 
Vibrio species.  This information has been used to educate consumers about the health risks 
of seafood, as well as to help determine host, food, and environmental risk factors.  
 
This reporting system was initiated by the Food and Drug Administration (FDA), CDC, and 
the Gulf Coast states (Alabama, Florida, Louisiana, Mississippi, and Texas) in 1988.  Since 
1997, many other states have also reported Vibrio isolates (Figure 1).  However, only 
toxigenic V. cholerae O1 and O139 were nationally notifiable; thus the number of Vibrio 
isolates is greater than reported.  Participating health officials collect clinical data, 
information about underlying illness, history of seafood consumption and exposure to 
seawater in the 7 days before illness, and conduct tracebacks of implicated oysters.  CDC 
serotypes all V. parahaemolyticus isolates received from state health departments, and 
screens for cholera toxin production and the O1, O139, and O141 serogroups in V. cholerae 
isolates. 
     
This report summarizes human Vibrio infections reported to CDC in 2005 using the reporting 
form for “Cholera and Other Vibrio Illness”.  Results are presented in two categories: V. 
cholerae isolates that produce cholera toxin (referred to as toxigenic Vibrio cholerae), and all 
other Vibrio isolates, including those V. cholerae isolates that do not produce cholera toxin.  
Results are presented separately for Gulf Coast states versus other states to be consistent with 
previous reports.  Additionally, results are presented by anatomic site of isolation.  It is 
important to note that isolation of some Vibrio species from a patient with illness does not 
necessarily indicate causation.  While many Vibrio species are well-recognized pathogens, 
the status of V. damsela, V. furnissii, V. metschnikovii, and V. cincinnatiensis as enteric or 
wound pathogens is less clear. 
 
Vibrio illnesses associated with Hurricane Katrina were reported to COVIS from eight states 
(Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, Oklahoma, and Texas).  
The species reported were 26 V. vulnificus (72%), 6 nontoxigenic V. cholerae (17%), 3 V. 
parahaemolyticus (8%), and 1 (3%) unidentified Vibrio species.  For patients with available 
information, 20 (91%) of 22 were considered wound infections because they reported having 
a wound either before or during exposure to Vibrio. 
 
In June 2006, the Council of State and Territorial Epidemiologists adopted a resolution to 
add all Vibrio species infections (vibriosis) to the list of nationally notifiable diseases 
reported to the National Notifiable Diseases Surveillance System (NNDSS).  Reporting of 
vibriosis is in addition to and distinct from reporting of cholera currently conducted through 
NNDSS.  The position statement, “National Reporting for non-cholera Vibrio Infections 
(Vibriosis),” can be found at http://www.cste.org/PS/2006pdfs/PSFINAL2006/06-ID-
05FINAL.pdf.  In addition to reporting through NNDSS, CDC requests that states collect 
information using the standard surveillance form for COVIS available at 
http://www.cdc.gov/foodborneoutbreaks/. 
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Isolates of toxigenic Vibrio cholerae 
In 2005, 12 patients with toxigenic V. cholerae were reported (Table 1).  Five patients were 
hospitalized and no deaths were reported.  All 12 patients were infected with toxigenic V. 
cholerae serogroup O1.  Infection was acquired through international travel for five sporadic 
cases (three cases acquired infection while traveling in Pakistan and two cases while traveling 
in the Philippines).   Exposure to domestic seafood was the source of infection for four 
patients, two of whom were a husband and wife in Louisiana who ate crab and shrimp 
harvested from the Gulf Coast.  The other two cases associated with domestic seafood ate 
seafood at two different locations in Hawaii.  Source of infection was unknown for three 
cases in Guam, of which two cases were related but had brief contact with each other and did 
not share any meals in the 2 weeks before illness onset.  These cases, however, did receive 
drinking water from the same municipal aquifer supply and ate finfish in the week before 
illness.  The third case in Guam reported eating tuna fish and shrimp in the week before 
illness.   
 
Other Vibrio isolates (excluding toxigenic V. cholerae)  
In 2005, 578 Vibrio isolates from 546 patients were reported to the Cholera and Other Vibrio 
Illness Surveillance System.  Among patients for whom information was available, 232 
(46%) of 506 were hospitalized and 40 (8%) of 485 died.  V. parahaemolyticus was isolated 
from 218 (40%) patients, and was the most frequently reported Vibrio species.  Of the 
patients infected with V. parahaemolyticus, 23% were hospitalized and 1% died.  V. 
vulnificus was isolated from 121 (22%) patients; 90% were hospitalized and 26% died.        
 
Geographic Location 
In 2005, CDC received 219 (40%) reports of Vibrio illness from Gulf Coast states, 143 
(26%) from Pacific Coast states, 151 (28%) from Atlantic Coast states (excluding Florida, 
which is included with Gulf Coast states), and 33 (6%) from inland states (Figure 1).  The 
most frequent Vibrio species reported from Gulf Coast states were V. vulnificus (39%), V. 
parahaemolyticus (23%), V. alginolyticus (11%), and non-toxigenic V. cholerae (11%).   
The most frequent Vibrio species reported from non-Gulf Coast states were V. 
parahaemolyticus (51%), V. alginolyticus (12%), V. vulnificus (11%), and non-toxigenic 
V. cholerae (10%). 
 
Anatomic Site of Isolation 
Among the 578 Vibrio isolates from all states, 243 (42%) were from stool, 105 (18%) from 
blood, and 164 (28%) from wounds.  In addition, 18 (3%) isolates were obtained from the 
ear, and 48 (8%) were from urine, sputum, or other site.  V. parahaemolyticus was the 
species most frequently isolated from stool (150 [62%] of 243 isolates from stool); V. 
vulnificus was the species most frequently isolated from blood (68 [65%] of 105 isolates 
from blood) and from wounds (51 [31%] of 164 isolates from wounds).   
 
Seasonality 
The number of patients from whom Vibrio species was isolated had a clear seasonal peak 
during the summer months (Figure 2).  The greatest frequency of cases occurred in August 
for Gulf Coast states and non-Gulf Coast states.   
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Exposures 
One hundred fifty-three (28%) patients reported having a wound either before or during 
exposure to Vibrio. Of those, 100 (65%) reported water activities such as swimming and 
boating, 34 (22%) reported handling seafood, and 40 (26%) reported contact with marine 
wildlife.  Excluding patients with wound infections, among the 255 for whom a food history 
was available, 223(87%) reported eating seafood in the 7 days before illness onset.  Among 
the 86 who reported eating a single seafood item (Table 4), 49% ate oysters (91% of whom 
consumed them raw), 10% ate shrimp, and 15% ate finfish. International travel in the 7 days 
before illness onset was reported by 41 (9%) of 449 patients for whom information was 
available.    
 
Laboratory 
For reports where laboratory confirmation was available, the state public health laboratory 
identified 239 (97%) of 247 human Vibrio isolates, excluding V. cholerae.  CDC received 
129 isolates of V. parahaemolyticus from 121 patients.  Of these, 117 were viable V. 
parahaemolyticus isolates that were serotyped and four were not viable.  Of the viable V. 
parahaemolyticus isolates, 29 (25%) from 12 health jurisdictions were serotype O4:K12 
(Colorado, Hawaii, Louisiana, Maryland, Maine, Montana, North Carolina, New York State, 
New York City, Oregon, Texas, and Washington); 17(15%) isolates from seven states were 
serotype O3:K6 (Arizona, Colorado, Georgia, Louisiana, Maryland, New Mexico, and 
Washington); 13 (11%) isolates from eight states were serotype O1:K56 (Hawaii, Louisiana, 
Maine, Montana, Oregon, Texas, Virginia, and Washington); and the remaining 57 isolates 
were one of 27 serotypes.  
 
Recent Publications 
Two cases of toxigenic Vibrio cholerae O1 infection after Hurricanes Katrina and Rita--
Louisiana, October 2005. MMWR Morb Mortal Wkly Rep. Jan 20 2006;55(2):31-32. 
 
Vibrio illnesses after Hurricane Katrina--multiple states, August-September 2005. MMWR 
Morb Mortal Wkly Rep. Sep 23 2005;54(37):928-931. 
 
Vibrio parahaemolyticus infections associated with consumption of raw shellfish--three 
states, 2006. MMWR Morb Mortal Wkly Rep. Aug 11 2006;55(31):854-856. 
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Table 1: Isolates of toxigenic V. cholerae, 2005 
        
 
State Age  Sex  Onset Exposure Serogroup Serotype 
Hawaii 85 F 4/8/2005 Domestic (seafood) V. cholerae O1 Ogawa 
Hawaii 34 M 5/10/2005 Domestic (seafood) V. cholerae O1 Ogawa 
Missouri 44 F 8/2/2005 Travel in Pakistan V. cholerae O1 Inaba 
New York 44 F 7/26/2005 Travel in Pakistan V. cholerae O1 Inaba 
Louisiana 43 M 10/15/2005 Domestic (crab and shrimp) - Gulf Coast V. cholerae O1 Inaba 
Louisiana 46 F 10/15/2005 Domestic (crab and shrimp) - Gulf Coast V. cholerae O1 Inaba 
Guam 32 M 10/26/2005 Unknown V. cholerae O1 Ogawa 
Guam 29 M 10/19/2005 Unknown V. cholerae O1 Ogawa 
Michigan 53 M 11/3/2005 Travel in Pakistan V. cholerae O1 Inaba 
Michigan 34 M 11/26/2005 Travel in the Philippines V. cholerae O1 Ogawa 
California 46 M 12/22/2005 Travel in the Philippines V. cholerae O1 Ogawa 
Guam 26 F 12/26/2005 Unknown V. cholerae O1 Ogawa 
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Table 2.  Number of Vibrio illnesses (excluding toxigenic V. cholerae) by species, 
complications, and site of isolation in patients from Gulf Coast states, 2005  
 
    Complications1   Site of Isolation 
Vibrio Species Patients Hospitalized Deaths Isolates Stool Blood Wound Other2
  N (%) n/N (%) n/N (%) N (%)         
V. alginolyticus 23 (11) 5/21 (24) 0/21 (0) 23 (10) 1 1 15 6 
V. cholerae  
(non-toxigenic) 3 23 (11) 12/20 (60) 3/19 (16) 23 (10) 12 5 1 4 
V. damsela 3 (1) 0/2 (0) 0/2 (0) 3 (1) 0 0 3 0 
V. fluvialis 11 (5) 7/11 (64) 2/11 (18) 12 (5) 5 2 4 1 
V. hollisae 3 (1) 2/3 (67) 0/3 (0) 3 (1) 1 0 1 1 
V. mimicus 4 (2) 2/4 (50) 1/4 (25) 4 (2) 3 0 0 1 
V. parahaemolyticus 50 (23) 17/44 (39) 2/46 (4) 52 (22) 20 4 21 7 
V. vulnificus 85 (39) 70/77 (91) 15/65 (23) 93 (39) 3 45 40 5 
Species not identified 9 (4) 4/9 (44) 0/8 (0) 9 (4) 5 0 1 3 
Multiple species4 8 (4) 4/8 (50) 1/6 (17) 18 (8) 6 4 8 0 
Total 219 (100) 123/199 (62) 24/185 (13) 240 (100) 56 61 94 29 
 
1 Denominators indicate patients for whom information is known. 
2 Includes ear, endotracheal secretion, sputum, and urine. 
3 Includes non-toxigenic V. cholerae O1 (1 isolate) and other non-toxigenic V. cholerae [non-O1 non-O139]  
  (22 isolates). 
4  V. parahaemolyticus and V. alginolyticus were isolated from two patients, V. parahaemolyticus and V. 
mimicus were isolated from one patient, V. parahaemolyticus and V. fluvialis were isolated from one patient, V. 
parahaemolyticus and an unidentified Vibrio species were isolated from one patient, V. parahaemolyticus and 
V. vulnificus were isolated from one patient, V. vulnificus and V. alginolyticus were isolated from one patient, 
and V. vulnificus and an unidentified Vibrio species were isolated from one patient. 
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Table 3.  Number of Vibrio illnesses (excluding toxigenic V. cholerae) by species, 
complications, and site of isolation in patients from non-Gulf Coast states, 2005  
 
    Complications1   Site of Isolation 
Vibrio Species Patients Hospitalized Deaths Isolates Stool Blood Wound Other2
  N (%) n/N (%) n/N (%) N (%)     
V. alginolyticus 40 (12) 9/37 (24) 0/37 (0) 40 (12) 2 1 25 12 
V. cholerae  
(non-toxigenic) 3 33 (10) 14/31 (45) 2/28 (7) 35 (10) 19 10 4 2 
V. damsela 4 (1) 3/4 (75) 0/4 (0) 4 (1) 0 0 3 1 
V. fluvialis 17 (5) 8/17 (47) 1/17 (6) 17 (5) 12 2 2 1 
V. furnissi 2 (0.6) 2/2 (100) 1/2 (50) 2 (0.6) 1 1 0 0 
V. hollisae 4 (1) 3/4 (75) 0/3 (0) 4 (1) 4 0 0 0 
V. mimicus 6 (2) 3/6 (50) 1/6 (17) 6 (2) 3 0 2 1 
V. parahaemolyticus 168 (51) 29/155 (19) 0/155 (0) 168 (50) 130 3 22 13 
V. vulnificus 36 (11) 31/35 (89) 10/32 (31) 37 (11) 1 23 11 2 
Species not identified 10 (3) 3/9 (33) 0/9 (0) 10 (3) 6 1 1 2 
Other 1 (0.3) 0/1 (0) 0/1 (0) 2 (1) 1 0 0 1 
Multiple species4 6 (2) 4/6 (67) 1/6 (17) 13 (4) 8 3 0 2 
Total 327 (100) 109/307 (36) 16/300 (5) 338 (100) 187 44 70 37 
 
1 Denominators indicate patients for whom information is known. 
2 Includes ear, peritoneal fluid, sinus, sputum, and urine. 
3 Includes non-toxigenic V. cholerae O1 (3 isolates), non-toxigenic V. cholerae    
   O139 (1 isolate), and other non-toxigenic V. cholerae [non-O1 non-O139] (29 isolates). 
4 V. parahaemolyticus and V. alginolyticus were isolated from one patient; V. parahaemolyticus and V. fluvialis 
were isolated from two patients; V. parahaemolyticus and an unidentified Vibrio species were isolated from one 
patient; V. alginolyticus and V. fluvialis were isolated from one patient; and V. cholerae non-O1, non-O139, V. 
fluvialis, and V. vulnificus were isolated from one patient. 
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Table 4.  Seafood exposure among patients with foodborne Vibrio infection (excluding toxigenic V. cholerae) who reported  
eating a single seafood item in the week before illness onset, 2005 (N=86) 
 
 Mollusks Crustaceans    
 Oysters Clams Mussels Shrimp Lobster Crab Crayfish 
Other 
Shellfish1 Finfish2 Total 
Ate (%) 42 (49) 3 (3) 1 (1) 9 (10) 1 (1%) 13 (15%) 2 (2%) 2 (2%) 13 (15%) 86 
% Ate raw  91 67 100 44 0 0 0 0 27 49 
 
1 Other shellfish reported: scallops 
2 Finfish reported:  ahi poke, catfish, flounder, perch, red snapper, rockfish, salmon, sunfish, sushi, tuna, yellow fin, and whiting.
Figure 1.  Number of patients with Vibrio isolates (excluding toxigenic V. cholerae), by 
state, 2005 (N=546 patients) 
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Figure 2.  Number of patients with Vibrio isolates (excluding toxigenic V. cholerae), by 
month of illness onset or specimen isolation, Gulf Coast states vs. other states, 2005 
(N=546) 
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